Financial Blog

Stay informed with the latest insights, analysis, and news from the world of finance and investing.

Kratos Announces the GEK800 Has Successfully Completed Altitude Testing
Stock Market

Kratos Announces the GEK800 Has Successfully Completed Altitude Testing

Engine Designed for Next-Gen CCA-type AircraftSAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, and GE Aerospace (NYSE:GE) today announced the successful completion of altitude testing. The companies also conducted durability and limits testing on its GEK800 engine designed to power the next generation of affordable unmanned aerial systems and CCA-type aircraft. The testing

Oct 31, 2025 Yahoo External Link
Novo Nordisk cuts 9,000 jobs as it looks to new weight-loss drugs
Wealth Management

Novo Nordisk cuts 9,000 jobs as it looks to new weight-loss drugs

STORY: :: Novo Nordisk Novo Nordisk has almost completed notifying employees impacted by the drugmaker's 9,000 job cuts.That’s according to a LinkedIn post by CEO Mike Doustdar Friday. As jobs were slashed globally, he added that the pace of informing people varied according to local laws. It’s part of Doustdar’s restructuring drive which he launched last month. And comes as Novo faces heated competition in the United States, the world's biggest drug market, against rival Eli Lilly.The $150 billion weight-loss drug market is booming and Novo’s setting its sights on newer heights.  :: Pfizer The Danish pharma giant and another major rival Pfizer are in a bidding war over obesity biotech Metsera’s hottest experimental treatments. The drugmakers are vying for access to its once-monthly GLP-1 injectable.Current popular injectables, including Novo’s Wegovy and Eli Lilly’s Zepbound, are weekly shots. Metsera is one of several companies developing experimental weight-loss drugs.The move signals an aggressive turn by Novo Nordisk a week after the ousting of most of the company's board.That was over concerns it was not moving fast enough in the obesity market.

Oct 31, 2025 Yahoo External Link